Literature DB >> 10783130

Molecular regulation of granulocyte macrophage colony-stimulating factor in human lung epithelial cells by interleukin (IL)-1beta, IL-4, and IL-13 involves both transcriptional and post-transcriptional mechanisms.

M Bergmann1, P J Barnes, R Newton.   

Abstract

Interleukin (IL)-1beta stimulates the release of granulocyte macrophage colony-stimulating factor (GM-CSF) from lung epithelial cells. To investigate the molecular mechanisms underlying GM-CSF regulation, we studied GM-CSF production, messenger RNA (mRNA) expression levels, and GM-CSF promoter activity in A549 human alveolar carcinoma cells stimulated with IL-1beta. Coincubation with IL-4 or IL-13 dose-dependently inhibited IL-1beta-induced GM-CSF release. Time-course studies of intracellular and extracellular protein release and mRNA expression indicated tight coupling of protein and mRNA synthesis within 6 h after stimulation. IL-4 and IL-13 both inhibited expression of GM-CSF mRNA and protein by 2 h after stimulation. Stable transfection of A549 cells, with GM-CSF promoter/ enhancer constructs containing up to 3.3 kb upstream of the transcription start site, revealed maximal activation by IL-1beta and phorbol 12-myristate 13-acetate (PMA) with a reporter containing the proximal promoter (-627 to +35). This excludes sequences further upstream from a major regulatory role in GM-CSF promoter activation by IL-1beta or PMA in these cells. IL-4 and IL-13 downregulated promoter activation but had no effect on GM-CSF mRNA half-life. However, IL-1beta activation of all constructs was far less pronounced than in Jurkat T cells, suggesting a requirement for additional mechanisms, possibly post-transcriptional, to potentiate the observed transcriptional induction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783130     DOI: 10.1165/ajrcmb.22.5.3889

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  13 in total

1.  Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells.

Authors:  Matthew C Catley; Joanna E Chivers; Neil S Holden; Peter J Barnes; Robert Newton
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

2.  Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells.

Authors:  N S Holden; W Gong; E M King; M Kaur; M A Giembycz; R Newton
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

3.  Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung.

Authors:  Geoffrey Heyer; Shahryar Saba; Robert Adamo; William Rush; Grace Soong; Ambrose Cheung; Alice Prince
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle.

Authors:  Thai Tran; Darren J Fernandes; Michael Schuliga; Trudi Harris; Linda Landells; Alastair G Stewart
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

5.  (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS.

Authors:  Brian N Chorley; Yuehua Li; Shijing Fang; Jin-Ah Park; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-29       Impact factor: 6.914

Review 6.  How corticosteroids control inflammation: Quintiles Prize Lecture 2005.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

7.  Nuclear factor-kappaB does not mediate the inhibitory effects of dexamethasone on granulocyte-macrophage colony-stimulating factor expression.

Authors:  Martin W Bergmann; Karl J Staples; Peter J Barnes; Robert Newton
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

8.  Evaled expression of ICAM-1 and its ligands in the rat spinal cord following lipopolysaccharide intraspinal injection.

Authors:  Junling Yang; Min Fei; Yangyang Gu; Linlin Sun; Zhiyun Ben; Dan Zhou; Jianping Chen; Youhua Wang; Ping Wang; Aiguo Shen; Chun Cheng
Journal:  Neuromolecular Med       Date:  2008-08-30       Impact factor: 3.843

9.  Mechanisms of suppression of alveolar epithelial cell GM-CSF expression in the setting of hyperoxic stress.

Authors:  Anne Sturrock; Timothy Vollbrecht; Mustafa Mir-Kasimov; Michael McManus; Steven E Wilcoxen; Robert Paine
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-24       Impact factor: 5.464

10.  Heterogeneity of glucocorticoid resistance in patients with bronchial asthma.

Authors:  Yasuhiro Matsumura
Journal:  Int J Biomed Sci       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.